Vivos Therapeutics, Inc. (VVOS) Stock Forecast
Data as of Aug 7, 2026Healthcare · Current price $0.33 (+1.30%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
VVOS vs Sector & Market
| Metric | VVOS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | +427.8% | +16315.7% | +17.2% |
| P/E Ratio | -0.37 | 3.59 | 36.06 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $31M | $31M | $31M | 3 |
| 2027-12-31 | $47M | $52M | $54M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-1.35 | $-1.28 | $-1.11 | 2 |
| 2027-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for VVOS?
The consensus among 3 analysts covering Vivos Therapeutics, Inc. (VVOS) is Buy with an average price target of $2.13.
What is the highest price target for VVOS?
The highest analyst price target for VVOS is $2.50.
What is the lowest price target for VVOS?
The lowest analyst price target for VVOS is $1.75.
How many analysts cover VVOS?
3 analysts have issued ratings for Vivos Therapeutics, Inc. in the past 12 months.
Is VVOS a buy or sell right now?
Based on 3 analyst ratings, VVOS has a consensus rating of Buy (2.00/5) with a +427.8% upside to the consensus target of $2.13.
What are the earnings estimates for VVOS?
Analysts estimate VVOS will report EPS of $-1.28 for the period ending 2026-12-31, with revenue estimated at $31M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.